Prexige Recalled in Australia

« Evidence Supports Fungal Infection as Cause of Chronic Sinusitis | Main | TraumaCure Inc.- WoundStat »

Sep19

L. Lewis

September 19, 2007

Know More: Drug Recall Anit-Inflammatory, Drug Recall, Prexige, TGA

Australia’s Therapeutic Goods Administration (TGA) has ordered the recall of the anti-inflammatory drug Novartis AG’s Prexige. TGA decided on the recall after the medication was linked to two deaths. Claiming to be the first country to issue the recall, the TGA based their decision on a review of eight cases that resulted in severe liver damage. Of the eight cases, two people died and two required liver transplants.

"As a result of those case reports we have taken this straight to our drug safety committee who met yesterday," said Rohan Hammett, the TGA's principal medical adviser.

Prexige is a non-steroid anti-inflammatory, a Cox-2 inhibitor, in the same class as Vioxx. Merck voluntarily recalled Vioxx in 2004 due to negative health reactions from patients.

With Novartis’ full support, the TGA is recommending that those taking Prexige seek out alternative medication.

More information on the TGA’s recall.

related entries

Canada Recalls Prexige from Market Oct 4, 2007
Naproxen Feb 6, 2008
Philippines Joins in Recall of Prexige Jan 23, 2008

2 Comments/Trackbacks

» Canada Recalls Prexige from Market from PharmaGazette
Health Canada announced today that it has stopped all sales of Novartis Pharmaceuticals Canada Inc.'s sale of the anti-inflammatory drug, Prexige.The cancellation of market authorization comes due to the risk of liver related illness such as h... [Read More]

» Philippines Joins in Recall of Prexige from PharmaGazette
On Friday Philippines health regulators, The Bureau of Food and Drugs, ordered Novartis to "immediately initiate a product recall and cease and desist from further importing, distributing, or selling Lumiracoxib (Prexige)".The Philippines joi... [Read More]

submit a trackback

TrackBack URL for this entry:

Comment Preview

« Evidence Supports Fungal Infection as Cause of Chronic Sinusitis | Main | TraumaCure Inc.- WoundStat »

Advertise

Watch the Digital Health Revolution

Related Resources

Advertise Here

Current News

Press Releases

resources

Bookmark this Page
Write for us
About us
Team
Contact
Subscribe
Advertise
Network Map
Privacy
Disclaimer

Support This Blog

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed

we support unitus

PRWeb

Influencer

PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 619

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 620

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 621

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 622

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 737

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 738

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 739

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 740

Pharmaceutical Industry discussion, review, analysis, news and information.

related entries

2 Comments/Trackbacks

submit a trackback

post a comment

Comment Preview

Advertise

Related Resources

recent comments

sponsored ads

topics

subscribe